PDEX
PRO DEX INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$72.55
+4.43%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$70.46
From 52W high−1.17%
Volume84464.00
Market cap$232.40M
P/E (TTM)17.2x
P/S (TTM)3.0x
Div yield—
Key dataSep 18, 2026
Open
$70.46
From 52W high
−1.17%
Volume
84464.00
Market cap
$232.40M
ValuationView details →
P/E (Fwd)
23.6x
EV/EBITDA
12.1x
P/E (TTM)
17.2x
RSI (14)
59.2
MomentumView details →
1D Return
+4.43%
YTD Return
+85.81%
SummaryUpdated Jun 1, 2026
Pro-Dex, Inc. (NASDAQ:PDEX) is a specialized medical device manufacturer founded in 1978 and headquartered in Irvine, California. The company went public in 1986 and has established itself as a niche player in the powered surgical instruments market. Pro-Dex primarily serves as an original equipment manufacturer (OEM) partner to larger medical device companies, designing and manufacturing precision surgical tools used in orthopedic, thoracic, and craniomaxillofacial procedures. The company has built its reputation on producing high-quality, autoclavable surgical instruments that meet the stringent requirements of modern operating rooms.
Similar companies
Latest newsMore news →
PRO DEX Inc, as lessee, amended its Standard Industrial/Commercial Multi-Tenant Lease with Irvine Business Properties, extending the lease term to September 30, 2030 and setting a new base rent schedule.2d agoPro-Dex, Inc. announced its fiscal 2026 fourth quarter and full-year financial results for the period ended June 30, 2026, reporting a 17% increase in net sales to $20.4 million and a 103% increase in gross profit to $7.1 million for the quarter.17d ago